RCC Laboratories India

What RCC Laboratories India does

RCC Laboratories India is a preclinical contract research organization (CRO) headquartered in Hyderabad's Genome Valley, providing OECD GLP-compliant safety assessment and testing services to pharmaceutical, agrochemical, biocide, chemical, personal care, biotechnology, vaccine, cosmetic, medical device, nutraceutical, household pesticide, and industrial chemical clients globally. The company runs a 55,000 sq. ft. integrated facility comprising analytical chemistry, genetic toxicology, pathology, ecotoxicology, and breeding infrastructure, accredited by Swiss Medic (since 2008), India's NGCMA (since 2011), AAALAC International (since 2016), CPCSEA, CIB-RC, DCA Telangana, and DSIR, and equipped with HPLC, GC-MS, LC-MS/MS, FTIR, UV/Vis, flow cytometry, inhalation exposure chambers with MMAD/GSD particle analysis, and validated GLP IT infrastructure including WINGS software, three-fold backup, biometric access, and electronic archives. Its service portfolio spans toxicology (general, genetic, dermal, ocular, inhalation, neuro), developmental and reproductive toxicology (DART), analytical chemistry, product chemistry (more than 65 physico-chemical parameters), environmental safety and ecotoxicology, REACH support across tonnage bands, cell line characterization (MCB/WCB/EOPC) per WHO/FDA/ICH Q5, and breeding of rat/mouse/hamster strains. RCC extends its portfolio via a European OECD GLP partner laboratory for specialized assays (DPRA, h-CLAT, YES/YAS, biodegradation, Beagle dog studies), and sells predominantly through a direct enterprise field-sales motion with a dedicated European sales representative, serving global multinational and emerging biotech clients with study-to-submission support across US-EPA, EU, Brazil, Argentina, Mexico, Australia, Canada, and CIB-RC jurisdictions.

RCC-India was established in 2005 as a wholly-owned subsidiary of RCC-Switzerland (which traces its CRO origins to 1977 in Basel), was acquired from the Swiss parent in 2009 to operate as an independent CRO, and now operates as a private, India-domiciled entity with 51–100 employees and no public revenue or funding disclosure. Its primary customer engagement model is project-based professional services contracting at quoted, study-specific pricing (not publicly disclosed), with revenue tied to GLP-compliant toxicology, regulatory submission, and breeding service volumes rather than software or product licensing.

RCC's value proposition rests on dual-jurisdictional OECD GLP status enabling globally accepted study data, ten years of historical control data reducing design uncertainty, vertical breadth (nine service lines across at least nine industry verticals), and a cost-arbitraged India delivery model coupled with a Swiss presence supporting European client engagement. Key risks include dependency on continued GLP accreditation renewal, reliance on European partner capabilities for specialized assays, and exposure to long-term shifts toward in vitro and computational alternatives to in vivo toxicology.

Name

RCC Laboratories India

Legal name

RCC Laboratories India Private Limited

Website

https://rcclabs.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

RCC Laboratories India is an OECD GLP-accredited preclinical contract research organization in Hyderabad providing toxicology, DART, analytical chemistry, ecotoxicology, REACH, cell line characterization, and breeding services to global pharmaceutical, agrochemical, biocide, chemical, and biotechnology clients.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

akta.pro secondary industries

Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Research & Trial Central Laboratories (HLAFAMAL), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)

Keywords

• Preclinical contract research
• GLP toxicology services
• Analytical chemistry testing
• Environmental safety testing
• Regulatory safety assessment

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Contract Research Services: RCC generates revenue through providing pre-clinical contract research services including toxicology studies, analytical chemistry, product chemistry, environmental safety testing, DART studies, breeding services, and cell line characterization. Services are provided on a project/contract basis following OECD GLP principles for pharmaceutical, agrochemical, biocide, chemical, personal care and biotechnology clients globally.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

RCC Laboratories India is a preclinical Contract Research Organization (CRO) providing GLP-compliant safety assessment and testing services for chemical and life science industries. Core offerings span toxicology (general, genetic, developmental/reproductive), analytical chemistry, product chemistry, environmental safety testing, REACH regulatory support, cell line characterization, and breeding of laboratory animals. The company serves pharmaceutical, agrochemical, biocide, chemical, personal care, and biotechnology clients with global regulatory submissions.

Product overview

RCC Laboratories India is a Contract Research Organization (CRO) providing pre-clinical testing services. The company operates a single integrated platform offering multiple laboratory testing services rather than a modular software product. The core service portfolio consists of Toxicology Services (including general toxicology, genetic toxicology, dermal toxicity, ocular toxicology, inhalation services, and neurotoxicity studies), DART Studies, Analytical Chemistry Services, Product Chemistry Services, Environmental Safety Testing, REACH Support Services, Breeding Services, Cell Line Characterization, and Partnered Services. These services are designed to support regulatory submissions for pharmaceuticals, agrochemicals, biocides, cosmetics, industrial chemicals, medical devices, and other life science products across global markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Toxicology Services Comprehensive toxicology safety assessment services for global regulatory registration of pharmaceuticals, agrochemicals, biocides, and chemicals, including general toxicology, genetic toxicology, nonclinical pathology, dermal toxicity, ocular toxicology, inhalation toxicology, infusion services, and neurotoxicity studies conducted under OECD Principles of GLP.
• DART (Developmental and Reproductive Toxicity) Studies Comprehensive developmental and reproductive toxicology studies including developmental screening, prenatal developmental, pre- and post-natal development, extended one-generation reproductive toxicity, and two-generation studies for regulatory submission in pharmaceutical, agrochemical and chemical product registration.
• Analytical Chemistry Services Analytical chemistry services for identification and quantification of active substances, formulated products, impurities and degradation products, including physical-chemical testing, analytical method development, bioanalysis in plasma samples, and stability testing.
• Product Chemistry Services Physico-chemical testing services for crop protection, industrial chemicals and biocidal products offering more than 65 physico-chemical parameters including explosivity, hydrolysis, photolysis, oxidizing properties, plus storage stability testing.
• Environmental Safety Testing Comprehensive environmental fate, ecotoxicology, endocrine disruptor screening and residue studies supporting agrochemical and industrial chemical regulatory submissions, including aquatic and terrestrial species testing at an independent ecotoxicology building.
• REACH Support Services REACH regulatory support services for EC1907/2006 compliance, providing physico-chemical, toxicology and ecotoxicology studies across tonnage bands (1-10t, 10-100t, 100-1000t, >1000t) plus dossier preparation using the IUCLID tool for chemical registration in the EU.
• Breeding Services Dedicated breeding services for rat, mouse and hamster strains (BALB/c mouse, Swiss Albino mouse, Sprague Dawley rat, Wistar rat, Golden Syrian Hamster) registered with CPCSEA and accredited by AAALAC International, with barrier and isolator facilities.
• Cell Line Characterization Cell substrate characterization services for biologics, biosimilar and vaccine manufacturing including origin, identity, genetic stability, and purity testing of Master Cell Banks (MCB), Working Cell Banks (WCB), and End-of-Production Cells (EOPC) per WHO TRS 978, FDA and ICH Q5 requirements, plus oncogenicity and tumorigenicity testing.
• Partnered Services Additional specialized studies supported through European OECD GLP accredited partner laboratories, including skin sensitization assays (DPRA, h-CLAT), endocrine receptor binding assays (YES/YAS), and e-fate studies including biodegradation and hydrolysis testing.

Quantifiable outcome

• Seamless transfer from testing to market launch
• +3 more outcomes

Named customers4 records

Segments8 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• European OECD GLP Accredited Lab PartnercoreTechnology or IntegrationRCC is supported by European OECD GLP accredited partner laboratory for additional study capabilities including specialized skin sensitization assays (DPRA, h-CLAT), endocrine receptor binding assays (YES/YAS), and certain biodegradation studies. This partnership enables RCC to offer extended service portfolio while maintaining GLP compliance for European regulatory submissions.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Charles River Laboratories: Global preclinical and CRO services leader with extensive toxicology, safety assessment, and animal model capabilities. Comparable to RCC's preclinical toxicology and DART services, but at vastly greater scale and broader service breadth.
• Eurofins Scientific: Global laboratory testing services group with significant agrochemical, environmental, and pharma safety testing businesses. Overlaps with RCC's product chemistry, environmental safety, and REACH services at much larger scale.
• Labcorp Drug Development (Covance): Global CRO offering preclinical toxicology, central lab, and clinical development services. Broadly comparable to RCC's preclinical and safety assessment portfolio, though at scale an order of magnitude larger.

Direct peers

• Syngene International: India-based integrated contract research services provider offering discovery, development, and preclinical services. Closest India-headquartered peer with comparable GLP toxicology and safety assessment offerings, though much larger and publicly listed.
• Aragen Life Sciences (formerly GVK Biosciences): India-based CRO offering preclinical safety assessment, DMPK, and toxicology services alongside discovery work. Directly comparable to RCC on preclinical toxicology capabilities and Hyderabad/India footprint.
• Sai Life Sciences: Hyderabad-headquartered CRO providing drug discovery, development, and safety assessment services. India-based peer with overlapping preclinical toxicology and DMPK offerings.
• TCG Lifesciences: India-based CRO with preclinical services including toxicology and safety assessment. Comparable niche scale and service portfolio focused on pharmaceutical and agrochemical clients.
• VIMTA Labs: Indian contract research and testing laboratory offering preclinical, clinical, and food/environmental testing. Overlaps with RCC's analytical, preclinical, and environmental testing services.

Emerging players

• WuXi AppTec: Asia-based global CRO/CDMO with preclinical toxicology and safety assessment operations. Comparable services and large scale; geographic overlap with RCC's Asian client base creates direct competition.
• Pharmaron: Global CRO with preclinical and safety assessment services across China, US, and UK. Comparable toxicology, DART, and regulatory study capabilities, particularly for pharma and agrochemical clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/rcclabs
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/rcc-laboratories-india-pvt-ltd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RCC Laboratories India